Gamma Medica-Ideas (GM-I) and GE Healthcare announced a partnership at the 55th annual meeting of the Society of Nuclear Medicine (SNM) in New Orleans, for which GE will be the exclusive distributor of GM-I's pre-clinical imaging products starting July 1.
Preliminary clinical findings indicate that when used with PET
technology, Lantheus Medical’s PET Myocardial Perfusion Imaging Tracer
demonstrates a favorable radiation dosimetry profile and is generally
well-tolerated, according to phase I data presented during the Society
of Nuclear Medicine (SNM) conference in New Orleans.
Syntermed, a nuclear medicine imaging and informatics software company,
released three new clinical diagnostic applications for neurologists
and cardiologists benefiting individuals with dementia, temporal lobe
epilepsy and heart failure at the Society for Nuclear Medicine
(SNM) annual meeting in New Orleans.
Robert Atcher, PhD, has been named as the 2008-2009 SNM president and
Michael Graham, MD, PhD, was selected as its president-elect at
the society’s 55th annual meeting, held this week in New Orleans.
Dominique Delbeke, MD, PhD, was chosen as vice president-elect and Mark
Wallenmeyer was elected as 2008–2009 president of SNM's Technologist
Section.
Research presented at the SNM annual conference this week in New
Orleans suggests that the use of molecular imaging in the management of
neurodegenerative disease, particularly for very early diagnosis of
Alzheimer’s disease, will enable researchers to monitor disease
progression, identifying those at risk and assessing the effectiveness
of new therapies.
Previous